Abstract

Introduction: Anemia is a common complication in end-stage renal disease (ESRD) patients on regular hemodialysis (HD). There has been a lot of interest recently in the non-classical effects of 25(OH) vitamin D (calcidiol), including its association with erythropoiesis and anemia pathogenesis. Objectives: To study the relation between anemia and vitamin D status in patients on regular HD. Results: This study is a cross-sectional study that included 90 patients on regular HD. Vitamin D status was classified into deficient (<20 ng/ mL), insufficient (20-30 ng/mL) and sufficient (>30 ng/mL). The level of vitamin D measured in the patients ranged between 3.5 to 66 ng/mL with median of 16.35 ng/mL. There were statistically significant positive correlations between vitamin D levels and the level of hemoglobin (P<0.001), serum calcium levels (P<0.001) and serum PO4 levels (P=0.023). Higher hemoglobin levels were statistically related to both higher vitamin D values (P<0.001) and higher serum calcium concentration P<0.001). Meanwhile, a significant negative correlation was found between hemoglobin levels and serum PTH values (P<0.001). Conclusion: There was a significant association between the status of vitamin D and the level of hemoglobin in dialysis population who were studied, independent from iron status. other associations with hemoglobin levels included PTH level and calcium.

Highlights

  • Anemia is a complication that is commonly encountered when caring for patients with chronic kidney disease (CKD)

  • Previous studies have found anemia to be associated with significant morbidity and mortality in end-stage renal disease (ESRD) patients on hemodialysis (HD)

  • This study aimed to evaluate the relation between anemia and vitamin D status in patients on regular HD

Read more

Summary

Introduction

Anemia is a complication that is commonly encountered when caring for patients with chronic kidney disease (CKD). The severity of the anemia worsens as the glomerular filtration rate (GFR) declines, with a prevalence reaching approximately 90% in patients with a GFR less than 30 mL/min [1]. Previous studies have found anemia to be associated with significant morbidity and mortality in end-stage renal disease (ESRD) patients on hemodialysis (HD). Anemia leads to progression of left ventricular hypertrophy with increased risk of myocardial infarction and heart failure [2,3]. Anemia has been associated with depression, cerebrovascular stroke, and fatigue and reduced exercise tolerance [4]. The pathogenesis of anemia in CKD is multifactorial. The fall in GFR is typically accompanied by a decrease in erythropoietin production. Several other factors contribute including absolute and functional iron deficiency, folate and vitamin B12deficiencies and suppression of erythropoiesis by uremia [5]

Objectives
Methods
Results
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call